Jason Ferrone
Fondateur chez Intrinsic Medicine, Inc.
Profil
Jason Ferrone is the founder of Intrinsic Medicine, Inc. (founded in 2018) and holds the title of Director.
He is also the founder of Intrinsic Medicine, Inc. (founded in 2018) and holds the title of Director.
Currently, Mr. Ferrone is the Chief Operating Officer & General Counsel at Creyon Bio, Inc. (since 2023).
Previously, he worked at Ionis Pharmaceuticals, Inc. (from 2007 to 2018) as the VP-Regulatory Affairs & Corporate Development (from 2016 to 2018).
He also worked at Dana-Farber Cancer Institute, Inc. as a Patent Manager.
Mr. Ferrone has a graduate degree from San Diego State University, an undergraduate degree from the University of California, Riverside, and a graduate degree from Suffolk University Law School.
Postes actifs de Jason Ferrone
| Sociétés | Poste | Début |
|---|---|---|
Intrinsic Medicine, Inc.
 Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Fondateur | 01/08/2018 |
Creyon Bio, Inc.
 Creyon Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart. | Directeur des opérations | 20/07/2023 |
Anciens postes connus de Jason Ferrone
| Sociétés | Poste | Fin |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2018 |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Jason Ferrone
| Suffolk University Law School | Graduate Degree |
| San Diego State University | Graduate Degree |
| University of California, Riverside | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Intrinsic Medicine, Inc.
Intrinsic Medicine, Inc. Miscellaneous Commercial ServicesCommercial Services Intrinsic Medicine, Inc. operates as a therapeutics company leveraging human milk biology to create new medicines to transform gut-brain axis (GBA) disorders with large populations underserved by current treatment options. The company was founded by Alexander Martinez and Jason Ferrone in August, 2018 and is headquartered in Seattle, WA. | Commercial Services |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
Creyon Bio, Inc.
Creyon Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Creyon Bio, Inc. is a pre-clinical stage drug development company based in San Diego, CA. The company is focused on developing precision oligonucleotide-based medicines (OBMs) such as ASOs, siRNAs, guide RNAs, RNA editing guides, mRNAs, and aptamers. Creyon Bio uses a data-first approach to generate powerful datasets and develop machine learning models to uncover the engineering principles that make precision OBMs possible for patient populations of all sizes. The CEO of the company is Christopher E Hart. | Commercial Services |
